We investigated culture supernatant proteins from the M1 serotype of Streptococcus pyogenes by two-dimensional gel electrophoresis and peptide mass mapping analysis, and characterized the single protein spots. Among them, we analysed the Spy0747 protein. This protein is homologous to the SsnA protein, a cell-wall-located DNase expressed in Streptococcus suis serotype 2. We designated the Spy0747 protein as SpnA. SpnA protein was also detected in the insoluble fraction of whole-cell lysates using shotgun proteomic analysis, suggesting that SpnA is also located in the cell wall. SpnA was expressed as a glutathione S-transferase-fusion protein in Escherichia coli. We confirmed that the recombinant protein had DNase activity that was dependent on Ca 2+ and Mg 2+ , like SsnA. Blood bactericidal assays and mouse infection model experiments showed that the spnA knockout strain was less virulent than the parental strain, thus suggesting that SpnA could play an important role in virulence. Using PCR, we found that the spnA gene was present in all clinical S. pyogenes strains we examined. Our results, together with a previous report identifying Spy0747 as a surface-associated protein, suggest that SpnA is an important cell-wall-located DNase that is generally produced in S. pyogenes and is involved in virulence.
INTRODUCTION
Streptococcus pyogenes is a Gram-positive bacterium infecting the upper respiratory tract, such as the tonsils and pharynx, and it also causes post-infection diseases such as rheumatic fever and glomerulonephritis. Furthermore, S. pyogenes causes many serious human diseases such as streptococcal toxic shock syndrome (STSS) (Cone et al., 1987; Cunningham, 2000) . Because of the worldwide prevalence of STSS, a number of studies have been undertaken to identify relevant virulence factors (Hauser et al., 1991; Reichardt et al., 1992) . These factors include M protein, streptococcal inhibitor of complement, streptococcal pyrogenic toxins, haemolysins, and several DNases (Cunningham, 2000) . DNases have been extensively characterized (McCarty, 1949; Miyakawa et al., 1985; Ferreira et al., 1992) . However, there was no direct evidence that DNases are virulence factors, until Sumby et al. (2005a) provided such evidence.
We have investigated streptococcal exoproteins using 2-dimensional gel electrophoresis (2-DE) (Tanaka et al., 2005; Sawai et al., 2007) . We have so far detected several DNases (Hasegawa et al., 2002a, b) and have analysed the influence of various culture conditions on production of these exoproteins (Nakamura et al., 2004) . In these comprehensive analyses of culture supernatant proteins, we detected another putative DNase protein, Spy0747, in the culture supernatant of S. pyogenes SF370. The Spy0747 protein is homologous to the SsnA protein, which is a cell-wall-located DNase expressed in Streptococcus suis serotype 2 that requires Ca 2+ and Mg 2+ for its activity (Fontaine et al., 2004) . Hence we designated the Spy0747 protein as SpnA. In the present study, we further characterized the SpnA protein and analysed its involvement in virulence using an in vitro blood bactericidal assay and a mouse infection model experiment.
METHODS
S. pyogenes strains. The S. pyogenes strains used in this study were SF370 (Ferretti et al., 2001 ) and clinical isolates from Japanese patients with S. pyogenes infection. One of the strains was 1529, which has only one point mutation in the covS gene compared to SF370 (data not shown). The profile of its supernatant proteins analysed by 2-DE is similar to that of SF370 ( Fig. 1 and Tanaka et al., 2005) . Bacteria were cultured in 25 ml brain heart infusion (BHI) broth Abbreviations: 2-DE, two-dimensional gel electrophoresis; GST, glutathione S-transferase; NET, neutrophil extracellular trap; STSS, streptococcal toxic shock syndrome.
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On: Sun, 20 Jan 2019 00:51:29 (Eiken Chemical) supplemented with 0.3 % yeast extract (Becton Dickinson) (BHI-YE) for 18 h at 37 uC without agitation.
2-DE analysis. Exoproteins from the culture supernatant were prepared as described previously (Hasegawa et al., 2002a, b) . In brief, sample pellets derived from 25 ml of bacterial culture supernatant were dissolved in 300 ml immobilized pH gradient (IPG) dehydration solution (GE Healthcare Biosciences), which consisted of 7.8 M urea, 2 M thiourea, 2 % 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 0.6 % dithiothreitol and 0.5 % IPG buffer. Aliquots (280 ml) of the samples were loaded onto 13 cm Immobiline DryStrip gels (pH 3-10; GE Healthcare Biosciences). First-dimension electrophoresis conditions and second-dimension SDS-PAGE separation were as described previously (Hasegawa et al., 2002a, b) .
Peptide mass mapping analysis. Sample peptide mixtures were prepared as described previously (Tanaka et al., 2005) . In brief, protein spots were excised from the gels, and the peptide mixtures were extracted from the excised gel pieces using acetonitrile solution containing 0.1 % (v/v) trifluoroacetic acid. The extracts were dried and stored at 4 uC before mass analysis. Nanoelectrospray tandem mass analysis was performed as described previously (Tanaka et al., 2005) . Proteins in the spots were identified with the program MASCOT (Matrix Science).
Shotgun proteomic analysis of cytoplasmic and membraneassociated proteins. Bacterial cells harvested by centrifugation were resuspended in 10 ml PBS and then disrupted with a French press. After a high-speed centrifugation at 14 000 g for 10 min, supernatant was recovered as a soluble fraction, and the resulting pellet was resuspended in PBS as an insoluble fraction. The soluble fraction was further concentrated with TCA/acetone as described previously (Tanaka et al., 2005) . Each protein mixture was digested with trypsin and the resulting peptide mixture was loaded onto an LC-NSI-MS/ MS instrument. Shotgun proteomic analysis was performed with an LTQ-Orbitrap XL mass spectrometer (ThermoFisher Scientific) combined with a Paradigm MS4 LC system (Michrom BioResources) equipped with a 75 mm i.d. capillary LC column using 45 min LC separations. Full MS spectra (400-2000 m/z, resolution of 100 000 each) were obtained with the Orbitrap XL and product ion spectra were obtained with top3 data-dependent MS/MS scans of the LTQ. The collected product ion mass lists were subjected to the program MASCOT and proteins with more than two peptide fragments were identified. Shotgun proteomic analysis was performed in duplicate for each soluble or insoluble protein fraction.
Purification of recombinant protein and assay for DNase activity. A DNA fragment containing the spnA gene was amplified by PCR with primers 0747-n1 (CGGGATCCATGAT-TAACAAGAAATGTAT) and 0747-c1 (CCCTCGAGCTATGATT-CCTTTTTGCCTT), which have BamHI and XhoI restriction sites, respectively, and 1529 genome DNA as a template. After confirmation of the sequence, the BamHI/XhoI-digested fragment of the PCR product was cloned into the same restriction site of the pGEX4T-1 vector (GE Healthcare Biosciences). The procedure for the glutathione S-transferase (GST)-fusion protein was performed according to the manufacturer's instructions. To assess DNase activity, 0.5 mg of plasmid DNA was mixed with the recombinant protein in the presence or absence of 1 mM Ca 2+ and Mg 2+ at 37 uC for 2 h followed by electrophoresis in 1 % agarose gel.
Creation of the spnA knockout mutant and spnA complemented strain. A nonpolar inactivated mutant of the spnA gene was constructed by double-crossover allelic replacement in the chromosome of S. pyogenes 1529. A DNA fragment of spnA was amplified with oligonucleotide primers 0747-n1 and 0747-c1 (fragment 1) to construct a plasmid for the spnA knockout mutant. Both the BamHI/ DraI-digested N-terminal fragment 1 (approx. 460 bp) and the spc1 DNA fragment containing aad9 (promoterless spectinomycin-resistance gene) obtained from an SmaI-digested fragment of pSL60-1 (Lukomski et al., 2000) were cloned into the BamHI-SmaI site of the pGEM-7Zf(+) vector (Promega); the resultant plasmid was named Q66. The HincII/XhoI-digested C-terminal fragment 1 (approx. 380 bp) was cloned into the SmaI-XhoI site of plasmid Q66; the resultant plasmid was named Q70. Finally, the BamHI-SphI fragment of the Q70 plasmid was cloned into the BamHI-SphI site of plasmid pFW12 (Lukomski et al., 2000) . This plasmid (spnA : : aad9/pFW12) is a suicide vector for S. pyogenes. For preparation of competent cells, strain 1529 was harvested at early-to mid-exponential phase (OD 660 0.4-0.5) and washed twice with 0.5 M sucrose buffer. The constructed suicide vector was transformed into the strain by electroporation. Conditions of electroporation were 1.25 kV mm
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, 25 mF capacitance and 200 V resistance, using a Gene Pulser II (Bio-Rad). After incubation at 37 uC for 3 h, competent cells were spread onto BHI-YE agar plates containing spectinomycin (final concentration, 100 mg ml
). Selected colonies on the plates were cultured. Cultured bacteria were washed once with saline, resuspended in 10 mM Tris/ 1 mM EDTA, and boiled for 10 min. Genomic DNA was obtained from the supernatant of boiled bacteria. Double-crossover replacement with genomic DNA was analysed by PCR. Successful doublecrossover replacement was further confirmed by DNA sequencing. The mutant has an internal deletion of the DNA encoding 633 of the 910 amino acids of the SpnA protein. To construct a plasmid for spnA complementation, the DNA fragment of spnA was amplified with oligonucleotide primers 0747-n2 (CAAACAGAAAGTGTATCCCA) and 0747-c2 (CGACTCTTTATGAACTGCAA), using PrimeSTAR HS DNA polymerase (Takara). The fragment was treated with T4 polynucleotide kinase and ligated into the SmaI site of plasmid pLZ12-Km2 (Okada et al., 1998) . The protocol for transformation was the same as described above, except that the competent cells were spread onto BHI-YE agar plates containing spectinomycin and kanamycin (final concentrations, 100 and 200 mg ml 21 , respectively).
Lancefield bactericidal assay. Lancefield bactericidal assays (Lancefield, 1957; DeMaster et al., 2002) were performed as follows. Approximately 1000 c.f.u. of a strain in the late-exponential phase of growth was added to 1 ml of heparinized human whole blood and rotated at 37 uC. Diluted samples of blood were plated on BHI-YE agar plates at the indicated time points to determine the number of Mouse model of invasive skin and soft tissue infection. The ability of S. pyogenes to cause local skin lesions in mice after subcutaneous inoculation was assessed using a procedure modified as described elsewhere (Ashbaugh et al., 1998) . In brief, parental, mutant and complemented cells of S. pyogenes were harvested after 16 h of growth on a BHI-YE agar plate. These cells were harvested with appropriate antibiotics into 1 ml PBS and then centrifuged at 2000 g for 2 min. The pellets were diluted in PBS to 1610 8 c.f.u. in 100 ml and then injected (with a 25-gauge needle) under the skin surface of 3-week-old female Slc : ICR mice that had been anaesthetized by ketamine-xylazine injection (13 mice per treatment group). The number of c.f.u. injected was verified for each experiment by plating bacteria on BHI-YE agar plates and then counting c.f.u. The mice were observed daily for lesion and necrosis formation. Lesion sizes (length by width) were measured, with length determined at the longest point of the lesion. Survival data were assessed by KaplanMeier survival analysis and tested for significance by the log-rank test. Lesion size data were tested for significance using a paired 2-tailed t test. All animal procedures were approved by the Institutional Animal Care and Use Committee at Nagoya City University.
Detection of the spnA gene in clinically isolated S. pyogenes strains. PCRs for detection of the spnA gene were performed with chromosomal DNA as the template and oligonucleotides 0747-n1 and 0747-c1.
RESULTS
Identification of the SpnA (Spy0747) protein in the culture supernatant of SF370 by 2-DE and peptide mass mapping analysis
We detected approximately 100 protein spots in the culture supernatant of SF370, using 2-DE and peptide mass mapping analysis. Among them, we identified the Spy0747 protein (Fig. 1) . According to the database, this protein possibly belongs to the endonuclease/exonuclease/phosphatase family (Dlakic, 2000) . Genes encoding this protein (more than 99.4 % identity at the nucleotide level) are present in all S. pyogenes strains for which the whole genomes have been sequenced: M1 (Sumby et al., 2005b) , M2 (Beres et al., 2006) , M3 (Beres et al., 2002; Nakagawa et al., 2003) , M4 (Beres et al., 2006) , M5 (Holden et al., 2007) , M6 (Banks et al., 2004) , M12 (Beres et al., 2006) , M18 , M28 (Green et al., 2005) and M49 (McShan et al., 2008) . The homologous protein was reported as SsnA (for S. suis nuclease A) of S. suis serotype 2 (Fontaine et al., 2004) . We designated the Spy0747 protein as SpnA (for S. pyogenes nuclease A). The nucleotide sequence of the spnA gene of strain 1529, a serotype M1 strain isolated from an STSS patient in Japan, also completely matched its counterpart in the database of the University of Oklahoma (Ferretti et al., 2001 ) (data not shown).
Estimation of the topological location of SpnA by proteomic analysis Severin et al. (2007) reported that Spy0747 is one of the surface-associated proteins of S. pyogenes. To confirm their results, the proteins of whole bacterial cells were separated into the soluble and insoluble fractions and shotgun proteomic analysis was performed (see Supplementary  Table S1 , available with the online version of this paper). The insoluble fraction was expected to contain membraneassociated proteins, and 248 proteins were identified in this fraction. Among them, 29 proteins possessed characteristic membrane-spanning domains estimated with SOSUI (http:// bp.nuap.nagoya-u.ac.jp/sosui/) (Mitaku et al., 2002) and 31 possessed signal peptide sequences for a type I secretion system estimated with SignalP (http://www.cbs.dtu.dk/ services/SignalP/) (Emanuelsson et al., 2007) . M protein, which is well known as a major cell membrane component, was mainly detected in the insoluble fraction. Although several proteins were detected in both the soluble and insoluble fractions, the proteins possessing several membrane-spanning domains tended to belong to the insoluble fraction. SpnA was estimated to have two membranespanning domains with SOSUI, and was identified only in the insoluble fraction. In addition, the Prosite database revealed that SpnA has the LPxTG motif characteristic of surface proteins of Gram-positive cocci (LPKTG, the same as in SsnA). Hence our comparative proteomic analysis suggested that the SpnA tended to be a membraneassociated rather than a cytoplasmic protein.
Synthesis of recombinant proteins and assay for DNase activity
In addition to the possibility that SpnA is an endonuclease/ exonuclease/phosphatase family protein and its homology to SsnA nuclease, the amino acid sequence has weak homology to an extracellular nuclease of Synechocystis sp. (Kaneko et al., 1996) . To confirm its biochemical activity, we tried to obtain full-length recombinant protein from the predicted start ATG codon to the stop codon. We mixed the purified recombinant SpnA protein with substrate plasmid DNA. As shown in Fig. 2 , plasmid DNA was clearly digested by the recombinant protein in the presence of both 1 mM Mg 2+ and 1 mM Ca 2+ (lane 2); the plasmid DNA was not digested in the presence of only Mg 2+ (lane 3) or only Ca 2+ (lane 4). To rule out the possibility that contaminating E. coli proteins or GST protein itself had any nuclease activity, we used the recombinant protein including only the GST part prepared at the same time as a negative control. The plasmid DNA was not digested with even 10 times more recombinant GST protein in the presence of both 1 mM Mg 2+ and 1 mM Ca 2+ (lane 5).
In vitro blood bactericidal assay
DNase is considered to play an important role in virulence, especially via defence against neutrophil killing. To determine whether SpnA would affect the bactericidal function of human leukocytes, we conducted bactericidal assays with human blood. For this purpose, we constructed an spnA knockout mutant using double-crossover recomb-ination, and an spnA-complemented strain. The growth rates of the knockout mutant and complemented strain were almost the same as that of the wild-type (data not shown). We chose to use the serotype M1 clinical isolate because the M1 clone has exhibited unusual epidemiological virulence, unlike all other streptococcal strains (Aziz & Kotb, 2008) . The growth ratio of the spnA knockout was significantly less than that of the parental strain after 30 (P,0.0001), 60 (P,0.0001), 90 (P50.0008) and 120 (P50.0022) min (Fig. 3) . The growth ratio of the complemented strain was almost the same as that of the parental strain. These results suggest that the spnA knockout strain was killed more efficiently by human blood cells compared to the parental strain.
Analysis of SpnA virulence in a mouse infection model
To further examine virulence, we studied the effect of SpnA in a mouse infection model with the parental M1 serotype 1529, spnA knockout, and spnA-complemented strains. Thirteen mice were used for each group. As shown in Fig.  4(a) , the mice injected subcutaneously with the knockout strain survived longer than those injected with the parental strain (P50.00108). The spnA-complemented strain exhibited more virulence than the knockout strain, although less than the parental strain. Furthermore, as shown in Fig.  4(b) , the size of the lesion 72 h after injection was smaller in the mice injected with the knockout strain compared to those injected with the parental strain (P50.0005). The lesion size of the spnA-complemented strain was not significantly different from that of parental strain (P50.07). These results also suggest that SpnA plays an important role in virulence.
Distribution of the spnA gene in clinically isolated S. pyogenes strains Finally we examined the distribution of the spnA gene among S. pyogenes strains clinically isolated in Japan, among them strains of several M types that cause invasive disease, including STSS or pharyngitis. We checked 24 M1 (20 invasive and 4 pharyngitis), 13 M3 (9 invasive and 4 pharyngitis), 2 M4 (1 invasive and 1 pharyngitis), 1 M5 invasive, 1 M6 invasive, 1 M12 invasive, 1 M22 pharyngitis and 1 M28 pharyngitis strains. The spnA gene was detected in all strains, regardless of M serotype and clinical features (data not shown), consistent with the results of studies based on genome analysis (Sumby et al., 2005b; Beres et al., 2002 Beres et al., , 2006 Nakagawa et al., 2003; Holden et al., 2007; Banks et al., 2004; Smoot et al., 2002; Green et al., 2005; McShan et al., 2008) .
DISCUSSION
In the present study, we detected the Spy0747 protein in the culture supernatant of S. pyogenes SF370 by 2-DE and peptide mass mapping, and also in the insoluble fraction by shotgun proteomic analysis. Spy0747 is homologous to the SsnA (S. suis nuclease A) DNase protein of S. suis serotype 2 (Fontaine et al., 2004) . The recombinant protein exhibited DNase activity, which was Ca 2+ -and Mg 2+ -dependent like that of SsnA. Hence, we designated Spy0747 as SpnA (S. pyogenes nuclease A). All S. pyogenes strains express one or more DNase genes (Wannamaker, 1958; Miyakawa et al., 1985; Ferreira et al., 1992) , and recent genome studies have revealed that all S. pyogenes strains analysed contain several genes presumed to encode extracellular DNases. Extracellular streptococcal DNases have been considered as virulence factors. The four different types of DNase that have been reported are DNase A, B, C and D. This classification was based on serological, immunological and functional properties. The characterizations of these DNases were incomplete, and their specific roles in the pathogenicity were not shown. However, the overall contribution of DNase production to S. pyogenes virulence was shown in the studies of Sumby et al. (2005a) . Strain MGAS5005 has three genes that encode secreted DNases: spd3, sda1 (sdaD2) and spd. Sumby et al. (2005a) clearly showed that a triple DNase mutant strain was significantly less virulent in two mouse models of invasive infection. They also confirmed that Spd, Spd3 and Sda1 correspond to DNases B, C and D, respectively. Sda1 is phage-encoded (Aziz et al., 2004) and is a virulence factor that protects S. pyogenes against neutrophil killing by degrading the DNA framework of neutrophil extracellular traps (NETs) (Brinkmann et al., 2004; Buchanan et al., 2006) . Introduction of a prophage carrying the sda1 gene, together with another prophage carrying the speA2 gene, into the M1T1 clonal strain is considered to be the reason for emergence of the global and virulent M1T1 strain. Sda1 was also reported to provide selection pressure for a switch to invasive S. pyogenes infection through covRS mutation (Walker et al., 2007) .
All three of the above DNase genes are present in strain 1529, which we used in the blood bactericidal assay and the mouse infection experiment (Hasegawa et al., 2002a, b; Tanaka et al., 2005) . Although we detected SpnA in the culture supernatant, the role of SpnA as a DNase in the supernatant may be less important, because overall DNase activity in the culture supernatant of the spnA knockout strain was very similar to that of the parental strain (data not shown). However, we showed that the spnA knockout strain was efficiently killed by human blood and was less virulent than the parental 1529 strain in the mouse infection experiment. One possible reason could be the location of the DNase. Although we detected the SpnA protein as well as M protein, which is a typical membrane protein and may be released from the streptococcal surface (Herwald et al., 2004) , in the culture supernatant in SF370, we detected SpnA also in the insoluble fraction by shotgun proteomic analysis. In addition, SpnA was reported to be anchored to the cell wall (Severin et al., 2007) , as was the SpnA homologue SsnA (Fontaine et al., 2004) . Furthermore, SpnA contains the LPxTG motif of surface proteins of Gram-positive cocci, and was also predicted to be a membrane protein by the SOSUI program. Accordingly, although some fraction of SpnA could be released from the cell wall and detected in the supernatant, the locations where SpnA functions as DNase are considered to be different from the locations of other secreted extracellular DNases such as Spd, Spd3 and Sda1. Since the important function of DNase is considered to be protecting the bacteria from killing in NETs, DNases located on the cell wall may function more efficiently than extracellular DNase. Hence, the spnA knockout strain was more , the spnA knockout mutant (dotted line) and the spnA-complemented strain (dashed line). Slc : ICR mice were subcutaneously inoculated with each strain, and observed daily. Survival data were assessed by Kaplan-Meier survival analysis and tested for significance by the log-rank test. (b) Analysis of the lesion in murine subcutaneous challenge. Mice were observed daily for lesion and necrosis formation. Lesion sizes were measured after 72 h as described in Methods. The horizontal lines represent the mean lesion size. Lesion size data were tested for significance using a paired 2-tailed t test.
efficiently killed by human blood cells, and consequently was less virulent. Another possibility is that SpnA has functions other than those of DNase, because this protein is classified as a member of the endonuclease/exonuclease/ phosphatase family protein (Dlakic, 2000) . Thus far, we have not been able to detect phosphatase activity; further analysis is necessary.
We detected the spnA gene by PCR in all clinical isolates of S. pyogenes examined, regardless of the clinical features of the patients. This result, together with the reports that the spnA gene is present in all genomes of S. pyogenes so far sequenced, suggests that this gene is present in the chromosome, is not transmitted by plasmids, and is not involved in phage infection, in contrast to the sda1 gene. Additionally, reverse transcription PCR analysis of the mRNA expression of spnA in the parental and covS mutant strains showed no significant differences in spnA gene expression (data not shown). This result suggests that the mechanisms responsible for the regulation of spnA and sda1 are also different.
SsnA is the only protein expressing DNase activity in S. suis (Fontaine et al., 2004) . The Lancefield group C Streptococcus zooepidemicus strain (Beres et al., 2008) and S. suis serotype 2 (Chen et al., 2007) also possess homologous genes. This suggests that SpnA and its homologues are conserved in Streptococcus and play important roles. Cell wall DNase may play a role in the primitive defence mechanism against the host. Acquisition of extracellular DNases, some of which are transmitted from outside the bacterium, enhances DNase activity and allows the bacteria to become virulent via resistance to host-defence mechanisms such as NETs.
